Linolacort Hydro

Hydrocortisone, the active ingredient in Linolacort Hydro, is a corticosteroid presented as a topical formulation for cutaneous use. It reduces inflammation and immune responses in various skin conditions and is applied directly to the affected area. GNH USA supplies Linolacort Hydro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydrocortisone is a topical glucocorticoid used to manage inflammatory skin disorders. - Atopic dermatitis: alleviates redness, itching and swelling. - Psoriasis: reduces plaque formation and scaling. - Contact dermatitis: diminishes allergic or irritant reactions on the skin. - Insect bite reactions: eases local inflammation and discomfort.

Topical hydrocortisone may cause local and systemic reactions, most of which are mild and reversible.

Common Side Effects: - Burning or stinging sensation at the application site. - Skin dryness or peeling. - Pruritus or mild itching. - Erythema or mild redness. - Folliculitis or acneiform eruptions.

Serious or Rare Side Effects: - Skin atrophy or thinning with prolonged use. - Striae (stretch marks) formation. - Hypopigmentation or discoloration of the skin. - Secondary bacterial, fungal or viral infection. - Systemic adrenal suppression when large areas are treated. - Allergic contact dermatitis or urticaria.

When using Linolacort Hydro, consider the following safety measures. - Avoid application on infected or open wounds: may worsen infection. - Limit duration of continuous use: prolonged exposure increases risk of skin atrophy. - Do not apply to the face, groin or axillae unless directed: higher absorption risk. - Use caution in children and elderly: skin is more permeable. - Avoid occlusive dressings unless prescribed: can enhance systemic absorption. - Store at room temperature below 25°C: keep in original container, protect from moisture and direct sunlight.

Hydrocortisone can interact with other agents that affect steroid metabolism or skin integrity.

Major Interactions (Avoid): - Systemic corticosteroids: additive immunosuppression may increase infection risk. - Potent topical antibiotics or antifungals on the same area: may enhance local irritation.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may raise systemic hydrocortisone levels. - Skin barrier‑disrupting agents (e.g., harsh cleansers): can increase percutaneous absorption. - Antiviral or immunomodulatory creams: may alter therapeutic response.